Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities
Authors:
- Anil KumarAKAnil Kumar
- Israr AhmadIAIsrar Ahmad
- Bhupender S. ChhikaraBCBhupender S. Chhikara
- Rakesh TiwariRTRakesh Tiwari
- Deendayal MandalDMDeendayal Mandal
- Keykavous ParangKPKeykavous Parang
Open Access
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (5) , 1342-1346
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Src Inhibitor AZD0530 Reversibly Inhibits the Formation and Activity of Human OsteoclastsMolecular Cancer Research, 2009
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cellsMolecular Cancer Therapeutics, 2008
- The role of Src in prostate cancerAnnals of Oncology, 2007
- A Src/Abl Kinase Inhibitor, SKI-606, Blocks Breast Cancer Invasion, Growth, and Metastasis In vitro and In vivoCancer Research, 2007
- 1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Synthesis and Structure−Activity Relationships of Linear and Conformationally Constrained Peptide Analogues of CIYKYY as Src Tyrosine Kinase InhibitorsJournal of Medicinal Chemistry, 2006
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- A renaissance for SRCNature Reviews Cancer, 2004
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996